Acebutolol

CAS No:
37517-30-9 Category:
  • #LGM Pharma is a Acebutolol CAS# 37517-30-9 API supplier distributor based in the USA. Inquire about DMF, cGMP, price, availability, delivery, purity, and more.
  • #Questions? Call our customer API support number 1-(800)-881-8210.
  • #LGM Pharma offers this active ingredient but not the finished dosage forms.

Product Details:

  • CAS No: 37517-30-9
  • AHFC code: 24:24.0
  • Synonyms: Acebutolol HCL Acebutolol Hydrochloride Acebutololo Acetobutolol dl-Acebutolol
  • ATC Code: C07AB04
  • Chemical Formula: C10H17N
  • Molecular Weight: 336.4259
  • Assay/Purity: Typically NLT 98%
  • DrugBank: DB01193 (APRD00772)
  • SMILES: CCCC(=O)NC1=CC(C(C)=O)=C(OCC(O)CNC(C)C)C=C1
  • InChl: GOEMGAFJFRBGGG-UHFFFAOYSA-N
  • PubChem: 1978
  • IUPAC: N-(3-acetyl-4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)butanamide

Additional Details

Indication:
For the management of hypertension and ventricular premature beats in adults.
Pharmacodynamics:
Acebutolol is a cardioselective, beta-adrenoreceptor blocking agent, which possesses mild intrinsic sympathomimetic activity (ISA) in its therapeutically effective dose range. In general, beta-blockers reduce the work the heart has to do and allow it to beat more regularly. Acebutolol has less antagonistic effects on peripheral vascular _2-receptors at rest and after epinephrine stimulation than nonselective beta-antagonists. Low doses of acebutolol produce less evidence of bronchoconstriction than nonselective agents like propranolol but more than atenolol.
Mode of Action:
Acebutolol is a selective _1-receptor antagonist. Activation of _1-receptors by epinephrine increases the heart rate and the blood pressure, and the heart consumes more oxygen. Acebutolol blocks these receptors, lowering the heart rate and blood pressure. This drug then has the reverse effect of epinephrine. In addition, beta blockers prevent the release of renin, which is a hormone produced by the kidneys which leads to constriction of blood vessels.
Metabolism:
Subject to extensive first-pass hepatic biotransformation (primarily to diacetolol).
Toxicity:
Symptoms of overdose include extreme bradycardia, advanced atrioventricular block, intraventricular conduction defects, hypotension, severe congestive heart failure, seizures, and in susceptible patients, bronchospasm, and hypoglycemia.
General Reference:
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

API’s From Quality Manufacturers:

  • Cost effective materials based on specific requirements
  • Small quantities for initial research and larger development quantities towards product commercialization

 

  • Technical packages, letters of access to filed DMFs
  • Complete assistance in any regulatory filings
  • Top quality GMP certified manufacturers
  • Have necessary regulatory credentials

 

Related YouTube Videos